Alnylam Pharmaceuticals
ALNY
#459
Rank
S$67.72 B
Marketcap
S$512.61
Share price
-0.28%
Change (1 day)
44.74%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company